Cancer
Exome sequencing identifies cancer predisposition-gene carriers screening guidelines miss
Whole-exome sequencing identified carriers of predisposition genes for hereditary breast and ovarian cancer or Lynch syndrome who, under current guidelines, would not have qualified for genetic testing, according to study results.
Ovary removal at benign hysterectomy linked to higher mortality, cancer, CVD risk in some
Certain women who had their ovaries removed during a hysterectomy for benign conditions faced higher risks for all-cause mortality, CVD and cancer, a recent study showed.
Cancer death rates ‘must decline faster’ to achieve Moonshot goal
Cancer Moonshot’s goal of reducing the cancer death rate by at least 50% over the next 25 years will depend upon greater access to and utilization of cancer prevention interventions, according to a study presented at an NCI press briefing.
E-cigarette use rose amid outbreak of vaping-associated lung injury
E-cigarette use significantly increased among younger adults from 2019 to 2021, a time that spanned an outbreak of e-cigarette- or vaping-associated lung injury, known as EVALI, according to researchers at the American Cancer Society.
Long-term use of guselkumab in psoriasis treatment does not increase cancer risk
Long-term use of guselkumab in the treatment of psoriasis does not yield increased cancer rates compared with the general and psoriasis populations, according to a study.
Pregnancy-associated cancers increase overall 5-year mortality
Cancers diagnosed during pregnancy or 1 year post-partum had greater overall 5-year mortality compared with those not diagnosed near pregnancy, but risks were not the same for all cancer sites, researchers reported in JAMA Oncology.
ACCC advocacy agenda addresses reimbursement, care delays, treatment choice
The Association of Community Cancer Centers has announced its 2023 advocacy agenda, which includes four core focus areas to ensure members can provide quality, equitable cancer care in a variety of therapeutic settings.
Pulsed dye laser treatment benefits older adults with nonmelanoma skin cancer on hands
NEW ORLEANS — Having proven a low recurrence rate, two treatments of the 595 nm pulsed dye laser may be a viable therapy for nonmelanoma skin cancer on the hands of older adult patients, according to a poster presented here.
UChicago Medicine Comprehensive Cancer Center joins National Comprehensive Cancer Network
University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.
National Cancer Plan outlines eight goals, strategies to achieve Biden’s Moonshot vision
HHS on Monday released the National Cancer Plan, which includes eight goals and strategies to prevent cancer, reduce related mortality and improve the lives of people living with the disease.